Literature DB >> 16945266

[Diagnosis and treatment of pleural effusion].

Victoria Villena Garrido1, Jaime Ferrer Sancho, Luis Hernández Blasco, Alicia de Pablo Gafas, Esteban Pérez Rodríguez, Francisco Rodríguez Panadero, Santiago Romero Candeira, Angel Salvatierra Velázquez, Luis Valdés Cuadrado.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16945266     DOI： 10.1016/s1579-2129(06)60545-4

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN： 0300-2896            Impact factor:   4.872


× No keyword cloud information.
  19 in total

1.  Clinical-therapeutic management of thoracoscopy in pleural effusion: a groundbreaking technique in the twenty-first century.

Authors:  José Marcelo Galbis; Manuel Mata; Ricardo Guijarro; Rafael Esturi; Salvador Figueroa; Antonio Arnau
Journal:  Clin Transl Oncol       Date:  2011-01       Impact factor: 3.405

2.  Role of blind closed pleural biopsy in the managment of pleural exudates.

Authors:  Marco F Pereyra; Esther San-José; Lucía Ferreiro; Antonio Golpe; José Antúnez; Francisco-Javier González-Barcala; Ihab Abdulkader; José M Álvarez-Dobaño; Nuria Rodríguez-Núñez; Luis Valdés
Journal:  Can Respir J       Date:  2013-08-15       Impact factor: 2.409

3.  Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.

Authors:  Susana Herrera Lara; Estrella Fernández-Fabrellas; Gustavo Juan Samper; Josefa Marco Buades; Rafael Andreu Lapiedra; Amparo Pinilla Moreno; María Morales Suárez-Varela
Journal:  Lung       Date:  2017-06-27       Impact factor: 2.584

4.  Cytotoxic Natural Killer Subpopulations as a Prognostic Factor of Malignant Pleural Effusion.

Authors:  Susana Herrera Lara; Estrella Fernández-Fabrellas; Gustavo Juan Samper; Josefa Marco Buades; Rafael Andreu Lapiedra; Amparo Pinilla Moreno; María Morales Suárez-Varela
Journal:  Lung       Date:  2018-12-06       Impact factor: 2.584

5.  Long-term outcome of pleurodesis with OK-432 in metastatic breast cancer: a new risk model for success from an analysis of 75 cases.

Authors:  Nobuaki Matsubara; Kuniaki Itoh; Hirofumi Mukai; Shunji Nagai
Journal:  Int J Clin Oncol       Date:  2011-10-07       Impact factor: 3.402

6.  Predictive models of malignant transudative pleural effusions.

Authors:  Lucía Ferreiro; Francisco Gude; María E Toubes; Adriana Lama; Juan Suárez-Antelo; Esther San-José; Francisco Javier González-Barcala; Antonio Golpe; José M Álvarez-Dobaño; Carlos Rábade; Nuria Rodríguez-Núñez; Carla Díaz-Louzao; Luis Valdés
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

7.  Combining clinical and analytical parameters improves prediction of malignant pleural effusion.

Authors:  Luis Valdés; Esther San-José; Lucía Ferreiro; Francisco-Javier González-Barcala; Antonio Golpe; José M Álvarez-Dobaño; María E Toubes; Nuria Rodríguez-Núñez; Carlos Rábade; Adriana Lama; Francisco Gude
Journal:  Lung       Date:  2013-10-02       Impact factor: 2.584

8.  Multiple neurofibromas plus fibrosarcoma with familial NF1 pathogenicity: A case report.

Authors:  Yang Wang; Xiao-Fan Lu; Lu-Lu Chen; Ying-Wei Zhang; Bing Zhang
Journal:  World J Clin Cases       Date:  2020-04-06       Impact factor: 1.337

9.  Can ultrasound guidance reduce the risk of pneumothorax following thoracentesis? .

Authors:  Alessandro Perazzo; Piergiorgio Gatto; Cornelius Barlascini; Maura Ferrari-Bravo; Antonello Nicolini
Journal:  J Bras Pneumol       Date:  2014 Jan-Feb       Impact factor: 2.624

10.  Comparison of modified Borg scale and visual analog scale dyspnea scores in predicting re-intervention after drainage of malignant pleural effusion.

Authors:  Rogier C Boshuizen; Andrew D Vincent; Michel M van den Heuvel
Journal:  Support Care Cancer       Date:  2013-07-11       Impact factor: 3.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.